ZZATAB

This brand name is authorized in Nigeria.

Active ingredients

The drug ZZATAB contains one active pharmaceutical ingredient (API):

1	Albendazole UNII F4216019LN - ALBENDAZOLE
	Albendazole causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin, thus inhibiting its polymerization or assembly into microtubules.
	Read more about Albendazole

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-7590	Tablet	ZZATAB TAB 200 mg 1 X 2	42 CMS-PP-272497 ZZATAB ALBENDAZOLE 200MG Albendazole 200mg, Magnesium stearate, Talc powder, Corn starch, Methy paraben A4-7590 Drugs ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS Nigerian Products 1x2 OTC 6/30/2022 KCH CONSUMER HEALTHCARE LIMITED, 2B, KWAME NKRUMAH LANE, CROWN ESTATE LEKKI EPE EXPRESSWAY 8032317925 Kchconsumer@gmail.com KCH Consumer Healthcare Ltd., Plot 1-6 KCH Close, Off Atlantic Hall Expressway, Poka, Lekki Free Trade Zone, Epe, Lagos., Nigeria	06/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P02CA03	Albendazole	P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02C Antinematodal agents → P02CA Benzimidazole derivatives
Discover more medicines within P02CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-7590